DOI QR코드

DOI QR Code

Radiotherapy for initial clinically positive internal mammary nodes in breast cancer

  • Kim, Jina (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Chang, Jee Suk (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Choi, Seo Hee (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Kim, Yong Bae (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Keum, Ki Chang (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Suh, Chang-Ok (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Yang, Gowoon (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine) ;
  • Cho, Yeona (Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Kim, Jun Won (Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Lee, Ik Jae (Department of Radiation Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine)
  • Received : 2019.01.28
  • Accepted : 2019.03.20
  • Published : 2019.06.30

Abstract

Purpose: Internal mammary lymph node (IMN) involvement is associated with poor prognosis in breast cancer. This study investigated the treatment outcomes of initial clinically IMN-positive breast cancer patients who received adjuvant radiotherapy (RT), including IMN irradiation, following primary breast surgery. Materials and Methods: We retrospectively reviewed data of 95 breast cancer patients with clinically detected IMNs at diagnosis treated with surgery and RT between June 2009 and December 2015. Patients received adjuvant RT to the whole breast/chest wall and regional lymph node (axillary, internal mammary, and supraclavicular) areas. Twelve patients received an additional boost to the IMN area. Results: The median follow-up was 43.2 months (range, 4.5 to 100.5 months). Among 77 patients who received neoadjuvant chemotherapy, 52 (67.5%) showed IMN normalization and 19 (24.6%) showed a partial response to IMN. There were 3 and 24 cases of IMN failure and any recurrence, respectively. The 5-year IMN failure-free survival, disease-free survival (DFS), and overall survival (OS) were 96%, 70%, and 84%, respectively. IMN failure-free survival was significantly affected by resection margin status (97.7% if negative, 87.5% for close or positive margins; p = 0.009). All three patients with IMN failure had initial IMN size ≥1 cm and did not receive IMN boost irradiation. The median age of the three patients was 31 years, and all had hormone receptor-negative tumors. Conclusion: RT provides excellent IMN control without the support of IMN surgery. Intensity-modulated radiotherapy, including IMN boost for breast cancer patients, is a safe and effective technique for regional lymph node irradiation.

Keywords

References

  1. Qi XW, Du JZ, Tang P, et al. Clinical significance of internal mammary lymph node metastasis for breast cancer: analysis of 337 breast cancer patients. Surg Oncol 2018;27:185-91. https://doi.org/10.1016/j.suronc.2018.03.006
  2. Hassiotou F, Geddes D. Anatomy of the human mammary gland: current status of knowledge. Clin Anat 2013;26:29-48. https://doi.org/10.1002/ca.22165
  3. Zhang YJ, Oh JL, Whitman GJ, et al. Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: incidence and local control. Int J Radiat Oncol Biol Phys 2010;77:1113-9. https://doi.org/10.1016/j.ijrobp.2009.06.081
  4. Klauber-DeMore N, Bevilacqua JL, Van Zee KJ, Borgen P, Cody HS 3rd. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 2001;193:547-55. https://doi.org/10.1016/S1072-7515(01)01040-7
  5. Jochelson MS, Lebron L, Jacobs SS, et al. Detection of internal mammary adenopathy in patients with breast cancer by PET/CT and MRI. AJR Am J Roentgenol 2015;205:899-904. https://doi.org/10.2214/AJR.14.13804
  6. Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 1983;198:681-4. https://doi.org/10.1097/00000658-198312000-00002
  7. Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995;2:32-7. https://doi.org/10.1007/BF02303699
  8. Noguchi M, Ohta N, Thomas M, Kitagawa H, Miyazaki I. Risk of internal mammary lymph node metastases and its prognostic value in breast cancer patients. J Surg Oncol 1993;52:26-30. https://doi.org/10.1002/jso.2930520108
  9. Davidson T, Ben-David M, Galper S, et al. Use of (18)F-FDG PET-CT imaging to determine internal mammary lymph node location for radiation therapy treatment planning in breast cancer patients. Pract Radiat Oncol 2017;7:373-81. https://doi.org/10.1016/j.prro.2016.11.001
  10. Seo MJ, Lee JJ, Kim HO, et al. Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer. Eur J Nucl Med Mol Imaging 2014;41:438-45. https://doi.org/10.1007/s00259-013-2600-y
  11. Sachdev S, Goodman CR, Neuschler E, et al. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol 2017;12:199. https://doi.org/10.1186/s13014-017-0934-5
  12. Urban JA. Radical excision of the chest wall for mammary cancer. Cancer 1951;4:1263-85. https://doi.org/10.1002/1097-0142(195111)4:6<1263::AID-CNCR2820040613>3.0.CO;2-6
  13. Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer: results on a large series. Ann Oncol 2008;19:1553-60. https://doi.org/10.1093/annonc/mdn183
  14. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients: 30-year results of a randomised trial. Eur J Cancer 1999;35:1320-5. https://doi.org/10.1016/S0959-8049(99)00133-1
  15. Pardolesi A, Bertolaccini L, Brandolini J, Solli P. Robotic internal mammary lymphadenectomy: another possible minimally invasive approach to sampling lymph nodes in breast cancer patients. J Vis Surg 2018;4:71. https://doi.org/10.21037/jovs.2018.03.06
  16. Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013;24:2206-23. https://doi.org/10.1093/annonc/mdt303
  17. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 [Internet]. Bethesda, MD: US National Cancer Institute; 2010 [cited 2019 Feb 27]. Available from: https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf.
  18. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management: a systematic review. J Clin Oncol 2008;26:4981-9. https://doi.org/10.1200/JCO.2008.17.4862
  19. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981;47:170-5. https://doi.org/10.1002/1097-0142(19810101)47:1<170::AID-CNCR2820470128>3.0.CO;2-C
  20. Park HJ, Shin KH, Cho KH, et al. Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:e689-95. https://doi.org/10.1016/j.ijrobp.2010.11.061
  21. Noh JM, Kim KH, Park W, et al. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy. Breast 2015;24:637-41. https://doi.org/10.1016/j.breast.2015.07.016
  22. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985;202:702-7. https://doi.org/10.1097/00000658-198512000-00007
  23. Valdes-Olmos RA, Jansen L, Hoefnagel CA, et al. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med 2000;41:1500-6.
  24. Cao XS, Li HJ, Cong BB, et al. Axillary and internal mammary sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. Oncotarget 2016;7:74074-81. https://doi.org/10.18632/oncotarget.12615
  25. Liu J, Mao K, Jiang S, et al. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB. Oncotarget 2016;7:24848-59. https://doi.org/10.18632/oncotarget.6664
  26. Yang K, Choi DH, Kim H, et al. Outcome of radiotherapy in patients with internal mammary lymph node metastasis from breast cancer. In: Proceedings of 2018 KOSRO Annual Meeting; 2018 Oct 12; Seoul, Korea.
  27. Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med 2015;373:307-16. https://doi.org/10.1056/NEJMoa1415340
  28. Matzinger O, Heimsoth I, Poortmans P, et al. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925). Acta Oncol 2010;49:24-34. https://doi.org/10.3109/02841860903352959
  29. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987-98. https://doi.org/10.1056/NEJMoa1209825
  30. Chargari C, Castadot P, Macdermed D, et al. Internal mammary lymph node irradiation contributes to heart dose in breast cancer. Med Dosim 2010;35(3):163-8. https://doi.org/10.1016/j.meddos.2009.05.002
  31. Chung Y, Yoon HI, Kim YB, Ahn SK, Keum KC, Suh CO. Radiation pneumonitis in breast cancer patients who received radiotherapy using the partially wide tangent technique after breast conserving surgery. J Breast Cancer 2012;15:337-43. https://doi.org/10.4048/jbc.2012.15.3.337
  32. Chang JS, Park W, Kim YB, et al. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up. Int J Radiat Oncol Biol Phys 2013;86:867-72. https://doi.org/10.1016/j.ijrobp.2013.02.037
  33. Rudat V, Alaradi AA, Mohamed A, Ai-Yahya K, Altuwaijri S. Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiat Oncol 2011;6:26. https://doi.org/10.1186/1748-717X-6-26
  34. Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 2015;373:317-27. https://doi.org/10.1056/NEJMoa1415369

Cited by

  1. Coronary Event Analysis in Breast Cancer Patients Who Received Breast-Conserving Surgery and Post-Operative Radiotherapy: a Korean Nationwide Cohort Study vol.23, pp.3, 2019, https://doi.org/10.4048/jbc.2020.23.e30
  2. Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials vol.49, 2019, https://doi.org/10.1016/j.breast.2019.11.001
  3. Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer vol.12, pp.8, 2020, https://doi.org/10.3390/cancers12082103
  4. Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer vol.15, pp.1, 2019, https://doi.org/10.1186/s13014-020-1464-0
  5. Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery vol.55, 2019, https://doi.org/10.1016/j.breast.2020.12.011
  6. Clinical significance of internal mammary lymph node incidentally detected during free-flap breast reconstruction: Case report and systematic review of the literature vol.4, 2019, https://doi.org/10.1016/j.cpccr.2021.100078